, Aux médecins du service de Pneumologie qui m'ont accueilli pendant mon inter CHU à Paris: Pr Marie Wislez pour votre gentillesse et pour m'avoir également permis de réaliser cette thèse

D. Naccache, D. Canelas, D. Rozensztajn, D. Parrot, D. Issoufaly et al.,

I. I. , Délais de prise en charge des CP II.III.3.A Disponibilité des dates Au total, les dates de onze événements ou actes ont été recueillies lors de cette étude

, Cancer du Poumon. Institut National de Veille Sanitaire

R. Peto, S. Darby, and H. Deo, Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies, BMJ, vol.321, pp.323-332, 2000.

, Service des maladies chroniques et dispositifs d'accompagnement des malades-INCa/Département Diffusion des bonnes pratiques et information des malades, Cancers broncho-pulmonaires. Les Parcours de Soins/ Juillet, 2013.

P. Goldstraw, F. Chansky, and K. , The IASLC Lung Cancer Staging Projet: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eight) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, vol.11, issue.1, pp.39-51, 2015.

F. Barlesi, H. Blons, M. Beau-faller, I. Rouquette, . Ouafik-l-'houcine et al., BM) France: Results of routine EGFR, HER2, KRAS, BRAF, PI3KCA mutations detection and EML4-ALK gene fusion assessment on the first 10,000 non-small cell lung cancer (NSCLC) patients (pts), ASCO Meet Abstr, vol.31, p.8000, 2013.

J. Brahmer, K. L. Reckamp, and P. Baas, Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer, N Engl J Med, vol.373, issue.2, pp.123-158, 2015.

H. Borghaei, L. Paz-ares, and L. Horn, Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N Engl J Med, vol.373, issue.17, pp.1627-1666, 2015.

M. Reck, D. Rodriguez-abreu, and A. G. Robinson, Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-small-cell lung cancer, N Engl J Med, vol.375, pp.1823-1833, 2016.

G. Myrdal, M. Lambe, G. Hillerdal, K. Lamberg, and T. Agustsson, Effect of delays on prognosis in patients with non-small cell lung cancer, Thorax, vol.59, pp.45-49, 2004.

F. J. Gonzalez-barcala, J. A. Falagan, J. M. Garcia-prim, L. Valdes, J. M. Carreira et al.,

, Timeliness of care and prognosis in patients with lung cancer, Ir J Med Sci, vol.183, pp.383-90, 1971.

R. Diaconescu, C. Lafond, and R. Whittom, Treatment delays in non-small cell lung cancer and their prognostic implications, J Thorac Oncol, vol.6, issue.7, pp.1254-1263, 2011.

N. F. Kanarek, C. M. Hooker, and L. Mathieu, Survival after community diagnosis of early-stage non-small cell lung cancer, Am J Med, vol.127, issue.5, pp.443-452, 2014.

K. Kashiwabara, S. Koshi, K. Itonaga, O. Nakahara, M. Tanaka et al., Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor, Lung Cancer, vol.40, pp.67-72, 2003.

. Department and . Health, The NHS Cancer Plan : The Cancer Reform Strategy, 2007.

, Clinical and Organizational Factors in the Initial Evaluation of Patients With Lung Cancer: Diagnosis and Management of Lung Cancer

, American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, vol.143, pp.121-141, 2013.

S. Asch, E. Kerr, and E. Hamilton, Quality of care for oncologic conditions and HIV : a review of the literature and quality indicators. RAND Corporation, 2000.

. Cancer-care and . Ontario, Target wait times for cancer surgery in Ontario. Final report-revised, 2006.

, Dutch Association of Physicians for Pulmonary Disease and Tuberculosis. Non-small cell lung cancer guideline: staging and treatment. Van Zuiden Communications, 2004.

, Délais de prise en charge des quatre cancers les plus fréquents dans plusieurs régions de

. France-en, sein, poumon, côlon et prostate, 2011.

S. Alsamarai, Y. Xiaopan, and H. C. Cain, The effect of a Lung Cancer Care Coordination Program on Timeless of Care, Clinical Lung Cancer, vol.14, issue.5, pp.527-534

P. Nadpara, S. S. Madhavan, and C. Tworek, Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study, Cancer Epidemiol, vol.39, pp.1136-1180, 2015.

D. R. Gomez, K. Liao, S. G. Swisher, G. R. Blumenschein, J. J. Erasmus et al., Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival, Radiother Oncol, vol.115, pp.257-63, 2015.

G. Buccheri and D. Ferrigno, Lung cancer: clinical presentation and specialist referral time, Eur Respir J, vol.24, pp.898-904, 2004.

N. Leveque, L. Brouchet, B. Lepage, C. Hermant, L. Bigay-game et al.,

, Rev Mal Respir, vol.31, pp.208-221, 2014.

M. P. Devbhandari, P. Quennell, and P. Krysiak, Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study, J Cardiothorac Surg, vol.34, pp.479-483, 2008.

J. Virally, L. Choudat, and M. Chebbo, Epidemiologie et délais de prise en charge de 355 patients avec cancer du poumon, Rev Mal Respi, vol.23, pp.43-51, 2006.

, Plan cancer, Priorités et objectifs. INCa Février, 2014.

, Projet Stratégique. AP-HP, pp.2015-2019

, Projet de gestion des risques et qualité. AP-HP, pp.2015-2019

P. Brocken, B. A. Kiers, M. G. Looijen-salamon, P. N. Dekhuijzen, C. Smits-van-der-graaf et al., Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning, Lung Cancer, vol.75, pp.336-377, 2012.

D. S. Lo, R. A. Zeldin, and R. Skrastins, Time to treat : a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis, J Thorac Oncol, vol.2, issue.11, pp.1001-1007, 2007.

M. P. Devbhandari, M. N. Bittar, and P. Quennell, Are we achieving the current waiting time targets in lung cancer treatment? Result of a prospective study from a large United Kingdom teaching hospital, J Cardiothorac Surg, vol.2, p.5, 2007.

E. Salomaa, S. Sällinen, H. Hiekkanen, and K. Liippo, Delays in the diagnosis and treatment of lung cancer, CHEST J, vol.128, pp.2282-2288, 2005.

F. Leo, N. Venissac, and M. Poudenx, Multidisciplinary management of lung cancer: how to test its efficacy?, J Thorac Oncol, vol.2, issue.1, pp.69-72, 2007.

E. H. Wagner, A. Bowles, E. J. Greene, and S. M. , the quality of cancer patient experience: perspectives of patients, family members, providers and experts, Qual Saf Health Care, vol.19, pp.584-489, 2010.

E. H. Wagner, E. J. Ludman, A. Bowles, and E. J. , Nurse Navigators in Early Cancer Care : a randomized controlled trial, J Clin Oncol, vol.32, pp.12-18, 2014.

M. Mathews, D. Ryan, and D. Bulman, What does satisfaction with wait times mean to cancer patients ?, BMC Cancer, vol.15, pp.10-17, 2015.

, Evolution de l'activité d'HDJ de Pneumologie en nombre de patients et de séjours Avant parcours, Mai 2015 à Avril 2016 Après parcours: Mai, vol.2, 2016.

, * source: PMSI